Feasibility of mTOR inhibitor for the treatment of Fuchs endothelial corneal dystrophy

Nakayama G, Okumura N, Oshima T, Ueda E, Watanabe K, Tourtas T, Schlötzer-Schrehardt U, Kruse F, Koizumi N (2019)

Publication Type: Conference contribution

Publication year: 2019

Journal

Investigative Ophthalmology & Visual Science Association for Research in Vision and Ophthalmology (ARVO)

Publisher: ASSOC RESEARCH VISION OPHTHALMOLOGY INC

City/Town: ROCKVILLE

Conference Proceedings Title: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE

Event location: Vancouver, CANADA

Authors with CRIS profile

Ursula Schlötzer-Schrehardt Medizinische Fakultät Friedrich Kruse Lehrstuhl für Augenheilkunde

Involved external institutions

Doshisha University / 同志社大学 JP Japan (JP)

How to cite

APA:

Nakayama, G., Okumura, N., Oshima, T., Ueda, E., Watanabe, K., Tourtas, T.,... Koizumi, N. (2019). Feasibility of mTOR inhibitor for the treatment of Fuchs endothelial corneal dystrophy. In INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. Vancouver, CANADA: ROCKVILLE: ASSOC RESEARCH VISION OPHTHALMOLOGY INC.

MLA:

Nakayama, Genta, et al. "Feasibility of mTOR inhibitor for the treatment of Fuchs endothelial corneal dystrophy." Proceedings of the Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), Vancouver, CANADA ROCKVILLE: ASSOC RESEARCH VISION OPHTHALMOLOGY INC, 2019.

BibTeX: Download